Orthofix Medical's Net Sales To Grow At CAGR Of 6% To 7% From 2025 Through 2027

Shares of Orthofix Medical Inc. (OFIX), a medical technology company, have gained nearly 12% over the past three months and trade around $18.

This global spine and orthopedics company has a comprehensive portfolio of biologics, innovative spinal hardware, bone growth therapies, and specialized orthopedic solutions, among others. Its products are distributed in more than 60 countries worldwide.

Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe Now
Already subscribed? Sign in

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com